First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO.  To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO. To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Leveraging the Tumor Microenvironment for IO Therapy

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

Share Leveraging the Tumor Microenvironment for IO Therapy

Sign up to save your podcasts

Leveraging the Tumor Microenvironment for IO Therapy

Leveraging the Tumor Microenvironment for IO Therapy